Copyright
©The Author(s) 2022.
World J Orthop. Jun 18, 2022; 13(6): 564-573
Published online Jun 18, 2022. doi: 10.5312/wjo.v13.i6.564
Published online Jun 18, 2022. doi: 10.5312/wjo.v13.i6.564
Drug | Dosing | Efficacy | Adverse effects |
Bisphosphonates | |||
Alendronate | 10 mg daily, PO; 70 mg weekly, PO | RR of 0.55 in postmenopausal women compared to placebo | Esophageal irritation; Dyspepsia; Acute phase reaction; Atrial fibrillation; Musculoskeletal pain; Renal toxicity; Atypical fracture; Osteonecrosis of the jaw |
Ibandronate | 2.5 mg daily, PO; 150 mg monthly, PO; 3 mg every 3 mo, IV | RR between 0.50 and 0.62 in postmenopausal women compared to placebo | |
Risedronate | 5 mg daily, PO; 35 mg weekly, PO; 150 mg monthly, PO | RR of 0.64 in postmenopausal women compared to placebo | |
Zoledronate | 5 mg annually, IV | 7% increase in spine BMD; RR of 0.23 in postmenopausal women compared to placebo | |
Rankl inhibitors | |||
Denosumab | 60 mg every 6 mo, SQ | 68% decrease in incidence of radiographic vertebral fractures; 9.2% increase in lumbar spine BMD | Fatigue; Weakness; Diarrhea; Hypophosphatemia |
Hormones | |||
Raloxifene (SERM) | 60 mg daily, PO; 120 mg daily, PO | RR of 0.65 in postmenopausal women compared to placebo (60 mg); RR of 0.54 in postmenopausal women compared to placebo (120 mg); 2.6% increase in lumbar spine BMD (60 mg); 2.5% in lumbar spine BMD (120 mg) | Flu syndrome; Vasodilation; Endometrial cavity fluid; Peripheral edema |
Teriparatide (PTH) | 20 microg daily, SQ; 40 microg daily, SQ | 65% decrease in fracture risk (20 microg); 69% decrease in fracture risk (40 microg); 9% increase in lumbar spine BMD (20 microg); 13% increase in lumbar spine BMD (40 microg) | Nausea; Headache; Dizziness; Leg cramps |
Calcitonin (TH) | 200 mg daily, IN | 33% decrease in fracture risk; 1%-1.5% increase in lumbar spine BMD | Epistaxis; Rhinitis; Ulceration of nasal mucosa; Hypocalcemia |
Supplementations | |||
Vitamin D | 400 IU daily, PO | 15% decrease in fracture risk | - |
Calcium | 1500 mg daily, PO |
- Citation: Patel D, Liu J, Ebraheim NA. Managements of osteoporotic vertebral compression fractures: A narrative review. World J Orthop 2022; 13(6): 564-573
- URL: https://www.wjgnet.com/2218-5836/full/v13/i6/564.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i6.564